Literature DB >> 15168019

BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with Type 1 diabetes by delaying exposure to gluten.

S Schmid, D Buuck, A Knopff, E Bonifacio, A G Ziegler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15168019     DOI： 10.1007/s00125-004-1420-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  2 in total

1.  Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.

Authors:  Anette-G Ziegler; Sandra Schmid; Doris Huber; Michael Hummel; Ezio Bonifacio
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272

2.  Timing of initial cereal exposure in infancy and risk of islet autoimmunity.

Authors:  Jill M Norris; Katherine Barriga; Georgeanna Klingensmith; Michelle Hoffman; George S Eisenbarth; Henry A Erlich; Marian Rewers
Journal:  JAMA       Date:  2003-10-01       Impact factor: 56.272
  2 in total
  20 in total

1.  Environmental factors and primary prevention in type 1 diabetes.

Authors:  Jorma Ilonen; Outi Vaarala; Hans K Akerblom; Mikael Knip
Journal:  Pediatr Endocrinol Diabetes Metab       Date:  2009

2.  Human enterovirus infections in children at increased risk for type 1 diabetes: the Babydiet study.

Authors:  M-L Simonen-Tikka; M Pflueger; P Klemola; C Savolainen-Kopra; T Smura; S Hummel; S Kaijalainen; K Nuutila; O Natri; M Roivainen; A-G Ziegler
Journal:  Diabetologia       Date:  2011-09-20       Impact factor: 10.122

Review 3.  Can we prevent type 1 diabetes?

Authors:  Giovanna Beauchamp; Michael J Haller
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

4.  Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes.

Authors:  A-G Ziegler; E Bonifacio
Journal:  Diabetologia       Date:  2012-07       Impact factor: 10.122

Review 5.  Environmental factors in the development of Type 1 diabetes.

Authors:  Hui Peng; William Hagopian
Journal:  Rev Endocr Metab Disord       Date:  2006-09       Impact factor: 6.514

Review 6.  Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.

Authors:  Frank Waldron-Lynch; Kevan C Herold
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 7.  Primary and secondary prevention of Type 1 diabetes.

Authors:  J S Skyler
Journal:  Diabet Med       Date:  2013-02       Impact factor: 4.359

8.  Insulin autoantibodies with high affinity to the bovine milk protein alpha casein.

Authors:  K Adler; D B Mueller; P Achenbach; S Krause; A-K Heninger; A G Ziegler; E Bonifacio
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

9.  Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future.

Authors:  Marian Rewers; Peter Gottlieb
Journal:  Diabetes Care       Date:  2009-10       Impact factor: 17.152

Review 10.  Prevention of type 1 diabetes.

Authors:  Diane K Wherrett; Denis Daneman
Journal:  Endocrinol Metab Clin North Am       Date:  2009-12       Impact factor: 4.741
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.